CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma
暂无分享，去创建一个
Tetsutaro Hayashi | N. Oue | K. Sentani | M. Kaneko | D. Taniyama | T. Babasaki | K. Kuraoka | K. Mita | K. Kobatake | H. Kitano | Daiki Murata | S. Inoue | J. Teishima | K. Ikeda | K. Goto | M. Shigeta | Kenshiro Takemoto | Yohei Sekino